Many early COVID-19 studies have low-quality design, risk low-value evidence, research finds

"Many early COVID-19 studies have low-quality design, risk low-value evidence, research finds Many early clinical studies of COVID-19 fail to meet quality standards, raising concerns that the data could be of little meaningful use, research finds. By Mandy Erickson The COVID-19 pandemic mobilized scientists around the world to start a flurry of clinical trials so they could better understand the new disease. However, many studies initiated before mid-May failed to..." Lire la suite